Ranbaxy Laboratories Quarterly Results

TypeUnAuditedUnAuditedUnAuditedUnAuditedUnAuditedUnAuditedUnAuditedUnAuditedUnAuditedUnAuditedUnAuditedUnAudited
Date Begin1-Oct-061-Jul-061-Apr-061-Jan-061-Oct-051-Jul-051-Apr-051-Jan-051-Oct-041-Jul-041-Apr-041-Jan-04
Date End31-Dec-0630-Sep-0630-Jun-0631-Mar-0631-Dec-0530-Sep-0530-Jun-0531-Mar-0531-Dec-0430-Sep-0430-Jun-0431-Mar-04
Gross Sales10159.811035.910562.37977.68820.48344.29820.278949515.48628.89742.78330
Excise Duty-101.3-132.8-125-122.4-171.4-197.9-292.4-159-187.4-158-228.1-205
Net Sales10058.510903.110437.37855.286498146.39527.8773593288470.89514.68125
Other Income294.8-190.9400.5337250.4556545.7706.4395.6494.9258.4733
Total Income10353.310712.210837.88192.28899.48702.310073.58441.49723.68965.797738858
Expenditure-8309.6-8931.7-9234.2-7229.8-8077.3-8821.2-8807.1-7381.1-8567-7024.8-7265.9-6824
Operating Profit2043.71780.51603.6962.4822.1-118.91266.41060.31156.61940.92507.12034
Interest-136-176-160.7-108.3-67.9-74.9-78.6-42.1-16.8-40.9-23.5-27
Gross Profit1907.71604.51442.9854.1754.2-193.81187.81018.21139.819002483.62007
Depreciation-254.6-292.1-283.7-287.2-269.6-259.5-261.3-222.1-221.8-166.3-222.3-208
Profit before Tax1653.11312.41159.2566.9484.6-453.3926.5796.19181733.72261.31799
Tax-262.4-113.3-160.9-64.54.3345.6-161.6-119-195.4-320.7-411.8-314
Profit after Tax1390.71199.1998.3502.4488.9-107.7764.9677.1722.614131849.51485
Extraordinary Items--226--491-------
Net Profit1390.7973.1998.3502.4979.9-107.7764.9677.1722.614131849.51485
Equity Capital1863.41863.318631862.41862.2186218611859.81858.91858.318571856
Forex earnings/Exports7122.87337.37181.65399.45896.8493264385920.16794.2-6145.35795
EPS3.732.612.681.352.63-0.294.113.643.897.69.968.01
Non Promoters Shares224319758242717776242655228242537805239155802239107599119452381120844087123827653126364317126231640126153746
Non Promoters % Shares60.1965.1365.1365.1264.2164.2164.1964.9866.616867.9767.96

No comments: